Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cardioprotective Effect of Ranolazine in the Process of Ischemia-reperfusion in Adult Rat Cardiomyocytes, Efecto cardioprotector de la ranolazina en el proceso de isquemia-reperfusión en cardiomiocitos de rata adultos

  • Calderón-Sánchez, Eva
  • Domínguez-Rodríguez, Alejandro
  • López Haldón, José
  • Jiménez-Navarro, Manuel F.
  • Smani, Tarik
  • Ordóñez Fernández, Antonio
[EN] [Introduction and objectives] Ranolazine is used as a complementary treatment for angina in symptomatic patients who are inadequately controlled with first-line antianginal therapies. Ranolazine inhibits sodium voltage-dependent channels, suggesting their possible involvement in the reperfusion process by preventing the sodium and calcium overload that occurs during ischemia. In this study, we characterized the effect of ranolazine on calcium homeostasis in isolated adult cardiac myocytes from rats subjected to a simulated ischemia and reperfusion protocol., [Methods] The effects of ranolazine on changes in intracellular calcium concentration were evaluated at different times using field electrostimulation. The study of intracellular calcium was performed using microfluorimetry with the fluorescent indicator, Fura-2, and by confocal microscopy with the indicator, Fluo-3., [Results] We found that cardiomyocytes subjected to ischemia-reperfusion showed an increase in the diastolic calcium concentration and a decrease in the amplitude of intracellular calcium transients. The application of ranolazine during ischemia significantly improved intracellular calcium handling, preventing intracellular calcium overload, decreasing the diastolic calcium concentration, increasing the sarcoplasmic reticulum calcium load, and preserving the amplitude of the intracellular calcium transient, which was reflected by successful recovery in the process of excitation-contraction coupling during reperfusion. However, these effects of ranolazine did not occur when it was applied during reperfusion or when applied in both ischemia and reperfusion., [Conclusions] Ranolazine shows beneficial effects in cardiomyocytes exposed to ischemia/reperfusion but only when applied during ischemia. This effect is achieved through its improvement of calcium handling during ischemia., [ES] [Introducción y objetivos] La ranolazina se emplea como tratamiento complementario de la angina en pacientes sintomáticos insuficientemente controlados con los tratamientos antianginosos de primera línea. La ranolazina inhibe los canales de sodio operados por voltaje, lo cual indica su posible intervención en el proceso de reperfusión al prevenir la sobrecarga de sodio y calcio que se produce durante la isquemia. En este estudio, se ha caracterizado el efecto de la ranolazina en la homeostasis del calcio en miocitos cardiacos adultos de ratas a las que se aplicó un protocolo de isquemia y reperfusión simuladas., [Métodos] Se evaluaron los efectos de la ranolazina en los cambios de la concentración de calcio intracelular en diferentes momentos empleando electroestimulación de campo. El estudio del calcio intracelular se llevó a cabo mediante microfluorimetría utilizando el indicador fluorescente Fura-2 y por microscopia confocal utilizando el indicador Fluo-3., [Resultados] Se observó que los cardiomiocitos a los que se aplicaba la isquemia-reperfusión mostraban un aumento de la concentración de calcio diastólica y una disminución de la amplitud de los transitorios de calcio intracelular. La aplicación de la ranolazina durante la isquemia mejoró significativamente la regulación del calcio evitando la sobrecarga de calcio intracelular, reduciendo la concentración de calcio diastólica, aumentando la carga de calcio en el retículo sarcoplásmico y preservando la amplitud del transitorio de calcio intracelular, lo cual se reflejaba en una recuperación satisfactoria en el proceso de acoplamiento de excitación-contracción durante la reperfusión. Sin embargo, estos efectos de la ranolazina no se produjeron cuando el fármaco se aplicó solo durante la reperfusión o cuando se aplicó tanto en la isquemia como en la reperfusión., [Conclusiones] La ranolazina muestra unos efectos favorables en los cardiomiocitos expuestos a isquemia-reperfusión, pero solo cuando se aplica durante la isquemia. Este efecto se alcanza mejorando la regulación del calcio durante la isquemia., This study was supported by the Spanish Ministry of Science and Innovation (BFU2013-45564-C2-2); Instituto de Salud Carlos III (PI12/00941) and RIC (Red de Investigación Cardiovascular) (RD12/0042/0041; RD12/0042/0030); by The Andalusia Government (PI-0108-2012; P10-CVI-6095), and by the French ANR (Agence Nationale de la Recherche) (ANR-13-BSV1-0023-01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TRPs in Pain Sensation

  • Jardín, Isaac
  • López, José J.
  • Díez-Bello, Raquel
  • Sánchez-Collado, José
  • Cantonero, Carlos
  • Albarrán, Letizia
  • Woodard, Geoffrey E.
  • Redondo, Pedro C.
  • Salido, Ginés M.
  • Smani, Tarik
  • Rosado, Juan A.
According to the International Association for the Study of Pain (IASP) pain is characterized as an “unpleasant sensory and emotional experience associated with actual or potential tissue damage”. The TRP super-family, compressing up to 28 isoforms in mammals, mediates a myriad of physiological and pathophysiological processes, pain among them. TRP channel might be constituted by similar or different TRP subunits, which will result in the formation of homomeric or heteromeric channels with distinct properties and functions. In this review we will discuss about the function of TRPs in pain, focusing on TRP channles that participate in the transduction of noxious sensation, especially TRPV1 and TRPA1, their expression in nociceptors and their sensitivity to a large number of physical and chemical stimuli., This work was supported by MINECO (Grants BFU2013-45564-C2-1-P, BFU2013-45564-C2-2-P, BFU2016-74932-C2-1-P, and BFU2016-74932-C2-2-P) and Junta de Extremadura-FEDER (GR15029), JL is supported by Juan de la Cierva Program (JCI-2012-12934)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2

  • Calderón-Sánchez, Eva
  • Díaz Carrasco, Ignacio
  • Ordóñez Fernández, Antonio
  • Smani, Tarik
[Aims] Urocortin-1 (Ucn-1) is an endogenous peptide that protects heart from ischemia and reperfusion (I/R) injuries. Ucn-1 is known to prevent cardiac cell death, but its role in the transcription of specific genes related to survival signaling pathway has not been fully defined. The aim of this study was to investigate the molecular signaling implicated in the improvement of cardiac myocytes survival induced by Ucn-1., [Methods and Results] Ucn-1 administration before ischemia and at the onset of reperfusion, in rat hearts perfused in Langendorff system, fully recovered heart contractility and other hemodynamic parameters. Ucn-1 enhanced cell viability and decreased lactate dehydrogenase (LDH) release in adult cardiac myocytes subjected to simulated I/R. Annexin V-FITC/PI staining indicated that Ucn-1 promoted cell survival and decreased cell necrosis through Epac2 (exchange protein directly activated by cAMP) and ERK1/2 (extracellular signal–regulated kinases 1/2) activation. We determined that Ucn-1 shifted cell death from necrosis to apoptosis and activated caspases 9 and 3/7. Furthermore, mini-array, RT-qPCR and protein analyses of apoptotic genes showed that Ucn-1 upregulated the expression of CD40lg, Xiap and BAD in cells undergoing I/R, involving Epac2 and ERK1/2 activation., [Conclusions] Our data indicate that Ucn-1 efficiently protected hearts from I/R damage by increasing the cell survival and stimulated apoptotic genes, CD40lg, Xiap and BAD, overexpression through the activation of Epac2 and ERK1/2., This study was supported by Spanish Ministry of Economy and Competitiveness [BFU2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network "RIC" [RD12/0042/0041; PI12/00941]; and from the Andalusia Government [PI-0108-2012; P10-CVI-6095]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dynamic interaction of SARAF with STIM1 and Orai1 to modulate store-operated calcium entry

  • Albarrán, Letizia
  • López, José J.
  • Ben Amor, Nidhal
  • Martín-Cano, Francisco E.
  • Berna-Erro, Alejandro
  • Smani, Tarik
  • Salido, Ginés M.
  • Rosado, Juan A.
Ca2+ influx by store-operated Ca2+ channels is a major mechanism for intracellular Ca2+ homeostasis and cellular function. Here we present evidence for the dynamic interaction between the SOCE-associated regulatory factor (SARAF), STIM1 and Orai1. SARAF overexpression attenuated SOCE and the STIM1-Orai1 interaction in cells endogenously expressing STIM1 and Orai1 while RNAi-mediated SARAF silencing induced opposite effects. SARAF impaired the association between Orai1 and the Orai1-activating small fragment of STIM1 co-expressed in the STIM1-deficient NG115-401L cells. Cell treatment with thapsigargin or physiological agonists results in direct association of SARAF with Orai1. STIM1-independent interaction of SARAF with Orai1 leads to activation of this channel. In cells endogenously expressing STIM1 and Orai1, Ca2+ store depletion leads to dissociation of SARAF with STIM1 approximately 30s after treatment with thapsigargin, which paralleled the increase in SARAF-Orai1 interaction, followed by reinteraction with STIM1 and dissociation from Orai1. Co-expression of SARAF and either Orai1 or various N-terminal deletion Orai1 mutants did not alter SARAF-Orai1 interaction; however, expression of C-terminal deletion Orai1 mutants or blockade of the C-terminus of Orai1 impair the interaction with SARAF. These observations suggest that SARAF exerts an initial positive role in the activation of SOCE followed by the facilitation of SCDI of Orai1., Supported by MINECO (Grants BFU2013-45564-C2-1-P, BFU2013-45564-C2-2-P, BFU2011-24365 and RD12-0043-0016 (RETICEF)) and Junta de Extremadura-FEDER. JJL and LA are supported by Juan de la Cierva Program and MINECO fellowship BES-2011-043356, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Phospholipase A2 as a Molecular Determinant of Store-Operated Calcium Entry

  • Smani, Tarik
  • Domínguez-Rodríguez, Alejandro
  • Callejo-García, Paula
  • Rosado, Juan A.
  • Ávila-Medina, Javier
Rosado J. (eds)., Activation of phospholipases A2 (PLA2) leads to the generation of biologically active lipid products that can affect numerous cellular events. Ca2+-independent PLA2 (iPLA2), also called group VI phospholipase A2, is one of the main types forming the superfamily of PLA2. Beside of its role in phospholipid remodeling, iPLA2 has been involved in intracellular Ca2+ homeostasis regulation. Several studies proposed iPLA2 as an essential molecular player of store operated Ca2+ entry (SOCE) in a large number of excitable and non-excitable cells. iPLA2 activation releases lysophosphatidyl products, which were suggested as agonists of store operated calcium channels (SOCC) and other TRP channels. Herein, we will review the important role of iPLA2 on the intracellular Ca2+ handling focusing on its role in SOCE regulation and its implication in physiological and/or pathological processes., This work was supported by Spanish Ministry of Economy and Competitiveness [BFU2013-45564-C2-1-P and BFU2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network “RIC” [RD12/0042/0041;PI12/00941]; and from the Andalusia Government [PI-0108-2012; P10-CVI-6095]. A.D.R. is supported by ITRIBIS FP-7-REGPOT., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Regulation of Platelet Function by Orai, STIM and TRP

  • Berna-Erro, Alejandro
  • Jardín, Isaac
  • Smani, Tarik
  • Rosado, Juan A.
Rosado J. (eds)., Agonist-induced changes in cytosolic Ca2+ concentration ([Ca2+]c) are central events in platelet physiology. A major mechanism supporting agonist-induced Ca2+ signals is store-operated Ca2+ entry (SOCE), where the Ca2+ sensor STIM1 and the channels of the Orai family, as well as TRPC members are the key elements. STIM1-dependent SOCE plays a major role in collagen-stimulated Ca2+ signaling, phosphatidylserine exposure and thrombin generation. Furthermore, studies involving Orai1 gain-of-function mutants and platelets from Orai1-deficient mice have revealed the importance of this channel in thrombosis and hemostasis to those found in STIM1-deficient mice indicating that SOCE might play a prominent role in thrombus formation. Moreover, increase in TRPC6 expression might lead to thrombosis in humans. The role of STIM1, Orai1 and TRPCs, and thus SOCE, in thrombus formation, suggests that therapies directed against SOCE and targeting these molecules during cardiovascular and cerebrovascular events could significantly improve traditional anti-thrombotic treatments., This work was supported by MINECO (Grants BFU2013-45564-C2-1-P and BFU2013-45564-C2-2-P) and Junta de Extremadura-FEDER (GR15029). A. B-E is supported from UPF “MINECO – Plan Nacional de I+D+i(2008-2012) – SAF 2012-38140”., Peer reviewed